prednisolone / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 153 Diseases   74 Trials   74 Trials   10107 News 


«12...345678910111213...8586»
  • ||||||||||  prednisolone / Generic mfg.
    Review, Journal:  Acne agminata: dermoscopic features and a short review. (Pubmed Central) -  Feb 27, 2023   
    He achieved complete clinical resolution with oral prednisolone in 6 weeks. We also reviewed the literature regarding the reported treatment regimens used.
  • ||||||||||  prednisolone / Generic mfg.
    Trial completion date, Trial primary completion date:  Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation (clinicaltrials.gov) -  Feb 16, 2023   
    P3,  N=120, Recruiting, 
    We also reviewed the literature regarding the reported treatment regimens used. Trial completion date: Jun 2023 --> Jun 2025 | Trial primary completion date: Jun 2022 --> Jun 2024
  • ||||||||||  prednisolone / Generic mfg., mycophenolate mofetil / Generic mfg.
    Journal:  Bilateral Persistent Placoid Maculopathy Following COVID-19 Vaccines: Real or Coincidence? (Pubmed Central) -  Feb 5, 2023   
    Our case demonstrated a likely localised autoimmune inflammatory response to the COVID-19 vaccine affecting choriocapillaris. Further research is needed to clarify the association between COVID-19 vaccines and inflammatory placoid lesions of the retina.
  • ||||||||||  Good (B / 08) -  Feb 4, 2023 - Abstract #ECCMID2023ECCMID_5283;    
  • ||||||||||  prednisolone / Generic mfg., cyclophosphamide / Generic mfg.
    A rare case of coexistence of ANCA-associated vasculitis and malignancy () -  Feb 4, 2023 - Abstract #BSR2023BSR_372;    
    Co-existence of a vasculitis and a neoplastic disease is rare. ANCA positive vasculitis is most commonly reported with haematological malignancies but less so in solid tumours, presenting as a paraneoplastic phenomenon.
  • ||||||||||  Comirnaty (tozinameran) / Pfizer, Fosun Pharma, BioNTech
    Severe myocarditis with cardiogenic shock in adult-onset Still's disease after mRNA COVID-19 vaccination: a case of atypical presentation () -  Feb 4, 2023 - Abstract #BSR2023BSR_365;    
    Severe myocarditis with acute heart failure and cardiogenic shock is a possible initial presentation of adult-onset Still's disease after mRNA COVID-19 vaccination. After exclusion of more common aetiologies, it is important to consider adult-onset Still's disease as one of the differential diagnoses in the presence of compatible features following COVID-19 vaccination, such that appropriate and timely workup and treatment can be offered.
  • ||||||||||  Lynparza (olaparib) / Merck (MSD), AstraZeneca
    Trial completion date:  Study of Olaparib (Lynparza (clinicaltrials.gov) -  Jan 30, 2023   
    P3,  N=387, Active, not recruiting, 
    This case highlights the diversity of possible presentations of ocular syphilis, even in HIV-negative immunocompetent patients. Trial completion date: Dec 2022 --> Jun 2023
  • ||||||||||  prednisolone / Generic mfg.
    Review, Journal, Checkpoint inhibition:  Immune Checkpoint Inhibitors and Optic Neuropathy: A Systematic Review. (Pubmed Central) -  Jan 24, 2023   
    The only two patients who achieved full resolution of symptoms were treated with oral prednisolone...Although it remains uncommon, the incidence of optic neuropathy in this population exceeds that of the general population. Future research is needed to further characterise the risk profiles of patients who are most likely to develop ICI-associated optic neuropathy, and treatment pathways for these patients.
  • ||||||||||  Opdivo (nivolumab) / BMS
    Trial completion date, Trial primary completion date:  Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas (clinicaltrials.gov) -  Jan 9, 2023   
    P1/2,  N=18, Active, not recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2022 --> Jan 2023 Trial completion date: Dec 2023 --> Dec 2024 | Trial primary completion date: Dec 2022 --> Dec 2023
  • ||||||||||  prednisolone / Generic mfg.
    Journal:  Lack of Interference of Oclacitinib with the results of intradermal testing or allergen-specific IgE serology in Dermatophagoides farinae-sensitized beagle dogs. (Pubmed Central) -  Jan 6, 2023   
    Twenty-four (24) normal, healthy purpose-bred Beagle dogs were sensitized to house dust mites (HDM, Dermatophagoides farinae) and randomly assigned to placebo-, oclacitinib- (0.4 mg/kg/dose PO), or prednisolone-treated (0.5 mg/kg/dose PO) groups...Prednisolone significantly inhibited the measurable sensitivity of IDT, while oclacitinib did not. Neither prednisolone nor oclacitinib imposed significant effects on allergen-specific IgE serum levels, suggesting oclacitinib may have potential to be used in dogs concurrently undergoing intradermal skin testing and/or allergen-specific IgE serology testing without interference with test results.
  • ||||||||||  prednisolone / Generic mfg.
    Journal, IO biomarker:  Minimal symptom expression achievement over time in generalized myasthenia gravis. (Pubmed Central) -  Jan 3, 2023   
    An adequately powered steroid trial using patients reaching < 30 ml/min/1.73m eGFR by 3 years, as an outcome is warranted for AIN of unknown aetiology. From the early phases of immunotherapy, MSE is a good marker of therapeutic goal in patients with generalized MG.
  • ||||||||||  prednisolone / Generic mfg.
    Journal:  Bullous Pemphigoid in X-linked Alport Syndrome: A Case Report. (Pubmed Central) -  Dec 22, 2022   
    Oral prednisolone improved his symptoms gradually. Abundant tense blisters on the palms and soles might suggest an important role of the α5 (IV) chain in the integrity of BMZ.
  • ||||||||||  prednisolone / Generic mfg.
    Journal:  Polymyalgia rheumatica presenting as sternoclavicular arthritis: a case report. (Pubmed Central) -  Dec 18, 2022   
    Urological involvement such as ureteric strictures may be rare associations of primary systemic vasculitis. A high degree of suspicion combined with targeted investigations would allow early identification the polymyalgia rheumatica-giant cell arteritis syndrome in the presence of atypical manifestations, leading to improved patient outcomes.
  • ||||||||||  prednisolone / Generic mfg., methotrexate / Generic mfg.
    Journal:  Other iatrogenic immunodeficiency lymphoproliferative disorder induced by corticosteroid used for an autoimmune disorder. (Pubmed Central) -  Dec 16, 2022   
    Although methotrexate and tumor necrosis factor-alpha inhibitors cause oii-LPD, the association between corticosteroids and lymphomagenesis remains unknown...The diagnosis of AIHA was made in May 2016, and AIHA had been well-controlled for 5 years with oral prednisolone (PSL)...The large cells were partially positive for the Epstein-Barr encoding region in situ hybridization and latent membrane protein 1, which confirmed Epstein-Barr virus (EBV)-affected lymphomagenesis. To our knowledge, this is the first report of an oii-LPD case shown to be induced by corticosteroid use for AID.
  • ||||||||||  prednisolone / Generic mfg.
    Journal:  Severe alveolar bone resorption in Felty syndrome: a case report. (Pubmed Central) -  Dec 16, 2022   
    If their susceptibility to infection and pancytopenia-related bleeding can be managed, such patients can still receive comprehensive dental treatment, including teeth extractions and periodontal therapy. Cooperation among the dentist, hematologist, and patient is necessary to improve treatment outcomes and the patient's quality of life.
  • ||||||||||  hydroxychloroquine / Generic mfg., prednisolone / Generic mfg.
    Journal:  Primary Sjögren's syndrome-related Choroiditis in a Newly Diagnosed Older Adult. (Pubmed Central) -  Dec 10, 2022   
    The current case highlights that pSS, which usually manifests with dry eye and keratoconjunctivitis, may manifest with chronic choroiditis in both eyes as well. Based on our experience with this case, patients with clinically suspected bilateral choroiditis should be evaluated for pSS.
  • ||||||||||  prednisolone / Generic mfg., doxycycline / Generic mfg., cyclosporine / Generic mfg.
    Journal:  Negative-pressure wound therapy as an adjunct to treating pyoderma gangrenosum. (Pubmed Central) -  Nov 15, 2022   
    After multidisciplinary discussion, involving breast surgeons, oncology, dermatology and tissue viability, doxycycline was commenced alongside a portable negative-pressure device with twice weekly tissue viability input. The introduction of this device resulted in a rapid reduction in the wound size and facilitated healing with an excellent outcome.
  • ||||||||||  nintedanib / Generic mfg.
    Predictors of mortality in progressive fibrosing interstitial lung disease patients treated with Nintedanib: real-world data from a single ILD specialist centre (Abbey, 4th floor) -  Nov 15, 2022 - Abstract #BTSWM2022BTS_WM_257;    
    Longer median duration of Nintedanib administration was also associated with a statistically significant difference in mortality (20 months compared to 7 months, p<0.01). There was no statistically significant difference when considering age at commencement, sex, PFILD subtype or diagnostic criteria, smoking status, comorbidities, oxygen therapy, use of concomitant immunosuppression, acute ILD exacerbations, or radiological pattern.View this table:View inline P23 Table 1 Demographic, clinical, functional, radiological and survival characteristics of PFILD patients treated with NintedanibConclusions In this PFILD cohort, lower baseline FVC and DLCO, higher dose of prednisolone, and shorter duration of treatment with Nintedanib were associated with increased mortality.